文献速递腹部介入CTMR

160毫米覆盖范围CT灌注成像:两种经动脉化疗栓塞疗程治疗肝细胞癌相对磁共振成像表现的对比分析

Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

研究纳入19例患者37个肝细胞癌病灶,于首次和第二次TACE疗程前后行160毫米覆盖范围CT灌注和MRI检查,用mRECIST标准评估MRI疗效。结果显示首次TACE后完全缓解组的基线血流量和肝动脉血流量显著高于无完全缓解组,第二次TACE后有缓解组的基线达峰时间和平均通过时间显著低于无缓解组;首次和第二次TACE后的灌注参数与MRI疗效无统计学显著差异。

要点

  • 基线血流量和肝动脉血流量较高的病灶首次TACE后更易达完全缓解。
  • 基线达峰时间和平均通过时间较短的病灶第二次TACE后更易有缓解。
  • 首次和第二次TACE后的灌注参数与MRI疗效无统计学显著差异。

核心结论

  • 研究未发现首次TACE疗程后与第二次TACE疗程疗效相关的灌注参数,但基线灌注参数分析可能有助于更好地靶向可能对TACE疗程反应良好的病灶。

研究设计与样本

  • 研究纳入2015年10月至2017年9月间依据巴塞罗那临床肝癌指南的19例患者37个病灶,于首次TACE疗程前后及第二次TACE疗程后行160毫米覆盖范围CT灌注和MRI检查,以mRECIST标准评估MRI疗效。

诊断标准与关键数值

  • 以MRI的mRECIST标准定义疗效组:完全缓解(CR)、部分缓解(PR)、无缓解(NR)、缓解(包括CR和PR)、无完全缓解(NCR,包括PR和NR)。

临床应用与阅片要点

  • 基线血流量和肝动脉血流量较高的病灶首次TACE后完全缓解组显著高于无完全缓解组(血流量:118.8 vs. 76.3 mL/100 g/min,p=0.0231;肝动脉血流量:76 vs. 44.2 mL/100 g/min,p=0.0112)。

局限性

  • 研究未发现首次TACE疗程后与第二次TACE疗程疗效相关的灌注参数。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: The aim of this study was to assess hepatocellular carcinoma (HCC) response with CT perfusion parameters before and after two transarterial chemo embolization (TACE) courses compared with MRI, and to search for predictive factors of response.

METHODS: 37 lesions (19 patients) were included between October 2015 and September 2017, based on the Barcelona Clinic Liver Cancer guidelines. CT perfusion with 160-mm coverage and MRI were performed before and after the first TACE course, and after the second TACE course. Quantitative perfusion parameters were compared to the response assessed with MRI using mRECIST criteria, defining response groups: complete response (CR), partial response (PR), no response (NR), response (including CR and PR), no complete response (NCR, including PR and NR).

RESULTS: Pre-TACE blood flow (BF) and hepatic arterial blood flow (HABF) were significantly higher in lesions with post-TACE 1 CR than in those with NCR (BF: 118.8 vs. 76.3 mL/100 g/min, p = 0.0231; HABF: 76 vs. 44.2 mL/100 g/min, p = 0.0112). Pre-TACE time to peak (TTP) and mean transit time (MTT) were significantly lower in lesions with post-TACE 2 response than in those with NR (TTP: 31.5 vs. 46.1 s, p = 0.0313; MTT: 15.8 vs. 22.8 s, p = 0.0204). Post-TACE 1 and post-TACE 2 perfusion parameters did not exhibit any statistically significant differences relative to MRI response.

CONCLUSION: Our study did not find, after a first TACE course, perfusion parameters associated with a response to a second TACE course. However, baseline perfusion parameters analysis could lead to better therapeutic management of HCC by targeting lesions likely to respond well to TACE courses.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Bayle M, Clerc-Urmès I, Ayav A, et al. Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings. Abdom Radiol (NY). 2019. PMID: 30054686. doi:10.1007/s00261-018-1714-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。